Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil - a Prospective Collaborative Study
Conditions: Acute Lymphoid Leukemia; Minimal Residual Disease; Gene Abnormality; Chemotherapeutic Toxicity Interventions: Drug: Prednisone; Drug: Vincristin; Drug: Daunorubicin; Drug: Peg-asparaginase; Drug: Intrathecal Suspension; Drug: Cyclophosphamide; Drug: Cytarabine; Drug: Mercaptopurine; Drug: Methotrexate; Drug: Doxorubicin Sponsors: Instituto do Cancer do Estado de São Paulo; Servier Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Brazil Health | Cancer & Oncology | Leukemia | Methotrexate | Pediatrics | Prednisone | Research | Study | Toxicology